Friday, November 20, 2026
Log on to Zoom: 8:50 a.m. CST | Training hours: 9 a.m.–Noon CST
This introductory training provides mental health professionals with a clinical overview of psychedelic-assisted therapy, with an emphasis on ketamine-assisted psychotherapy. Participants will examine the history and major categories of psychedelic medicines, current theories about how these treatments support therapeutic change, and the roles of preparation, medicine sessions, and integration. The presentation will also address client screening, contraindications, and the ethical considerations of psychedelic-assisted therapy.
At the end of the webinar, you will be better equipped to:
» Differentiate ketamine, MDMA, and classic psychedelics according to their drug class, therapeutic applications, and current clinical context.
» Describe proposed mechanisms through which psychedelic-assisted therapies may support psychological change, including neuroplasticity, changes in rigid patterns of thinking, and increased access to emotional processing.
» Explain the roles of preparation, the medicine session, and integration within a psychedelic-assisted therapy model.
» Identify key considerations in determining client candidacy, including medical and psychiatric contraindications and factors that may increase clinical risk.
» Recognize ethical concerns related to altered states, including client vulnerability, suggestibility, informed consent, therapeutic touch, professional boundaries, and continuity of care.
Credit: 3 Continuing Education Units (CEUs)
Cost: $60 (Free for current AU Faculty/Field Liaisons and Field Instructors. Please note that this information will be verified)
Presenters: Shannon Daly, LCSW | Certified Ketamine-Assisted Psychotherapy Provider | Owner and Clinical Director of Rediscover Your Radiance, PLLC
Price:
$60.00